|   | |
| Clinical data | |
|---|---|
| Trade names | Aldrisone | 
| Other names | Delta-medrysone; [1] 6α-Methyl-11β-hydroxypregna-1,4-diene-3,20-dione; 6α-Methyl-11β-hydroxy-Δ1-progesterone | 
| Routes of administration | Topical, ophthalmic [1] [2] | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.047.587 | 
| Chemical and physical data | |
| Formula | C22H30O3 | 
| Molar mass | 342.479 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Endrisone (INN; also known as endrysone (USAN); brand name Aldrisone) is a synthetic, steroidal glucocorticoid which is or has been marketed in Italy by SIFI. [1] [2] [3] It is used as a topical and ophthalmic anti-inflammatory drug in the treatment of skin and eye conditions, respectively. [1] [2]